UFP Technologies stock (US9026731015): Director Croteau sells $635K in shares
14.05.2026 - 15:40:50 | ad-hoc-news.deUFP Technologies director Daniel C. Croteau sold 2,864 shares of the company's common stock at $221.71 per share in an open-market transaction, according to SEC Form 4 filing as of May 14, 2026. The transaction totaled approximately $635,000 and left Croteau with 855 shares held directly following the sale.
As of: May 14, 2026
By the editorial team – specialized in equity coverage.
At a glance
- Name: UFP Technologies Inc
- Sector/industry: Medical devices and custom-engineered components
- Headquarters/country: Newburyport, Massachusetts, United States
- Core markets: Medical device, specialty packaging, custom components
- Home exchange/listing venue: Nasdaq (UFPT)
- Trading currency: USD
UFP Technologies: core business model
UFP Technologies is a producer of custom-engineered components, products, and specialty packaging serving multiple markets including medical devices. The company operates in the medical device sector and manufactures specialized components for industrial and healthcare applications. As a Nasdaq-listed company, UFP Technologies maintains a market capitalization of approximately $1.70 billion and serves as a supplier to various end markets requiring precision-engineered solutions.
Main revenue and product drivers for UFP Technologies
The company generates revenue through the design and manufacture of custom components and specialty packaging solutions. Its product portfolio serves the medical device industry alongside other industrial sectors. UFP Technologies' business model centers on providing engineered solutions tailored to customer specifications, positioning it within the broader medical device supply chain and specialty manufacturing ecosystem.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Conclusion
Director Croteau's sale of approximately $635,000 in UFP Technologies shares represents a routine insider transaction in a company with a market capitalization near $1.7 billion. The filing reflects a reduction in his direct shareholding but does not necessarily indicate broader company developments. US investors monitoring UFP Technologies should track such insider transactions as one data point among earnings reports, guidance updates, and market conditions when evaluating the stock.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis UFPT Aktien ein!
Für. Immer. Kostenlos.
